$LFMD News

HC Wainwright & Co. Reiterates Buy on LifeMD, Maintains $10 Price Target

GLP-1 Users Turn to Telehealth to Access Weight Loss Drugs

LifeMD to Participate in Upcoming Investor Conferences

LifeMD (NASDAQ:LFMD) Q1 Beats Fails to Halt 13% After-Market Slide

LifeMD Affirms FY2026 Sales Guidance of $220.000M-$230.000M vs $223.588M Est

LifeMD Sees Q2 Sales $47.000M-$50.000M vs $53.989M Est

LifeMD Q1 EPS $(0.20) Beats $(0.23) Estimate, Sales $50.163M Beat $48.842M Estimate

BTIG Reiterates Buy on LifeMD, Maintains $10 Price Target

LifeMD Now Offers Eli Lilly's Foundayo To Eligible Patients Through Its Weight Management Program

LifeMD Appoints Atul Kavthekar CFO, Effective March 16, Succeeding Marc Benathen

LifeMD shares are trading higher after the company announced the appointment of Atul Kavthekar as CFO. Also, Mizuho upgraded the stock from Neutral to Outperform and raised its price target from $6 to $8.

LifeMD shares are trading higher after the company announced the appointment of Atul Kavthekar as CFO. Also, Mizuho upgraded the stock from Neutral to Outperform and raised its price target from $6 to $8.

LifeMD Appoints Atul Kavthekar CFO, Effective Immediately, Succeeding Marc Benathen

Mizuho Upgrades LifeMD to Outperform, Raises Price Target to $8

Freedom Capital Markets Maintains Buy on LifeMD, Raises Price Target to $10

LifeMD: Wegovy Pill, Net Cash, And Low Multiple Sets Up Longs For Possible Alpha

HC Wainwright & Co. Maintains Buy on LifeMD, Raises Price Target to $10

LifeMD shares are trading higher after the company reported better-than-expected Q4 financial results. Also, BTIG reiterated its Buy rating and maintaied a $10 price target.

BTIG Reiterates Buy on LifeMD, Maintains $10 Price Target

LifeMD Inc (NASDAQ:LFMD) Stock Falls 13% After Q4 Revenue and Earnings Miss